Calidi Biotherapeutics, Inc. SEC filings
Every EDGAR filing for Calidi Biotherapeutics, Inc. (CLDI), newest first, with AI summaries and stories.
- Ticker
- CLDI
- CIK
- 1855485
- Sector
- Biotech and pharma
- Latest filing
- Sep 25
Next: earnings expected ~Nov 13 · 10-Q expected ~Nov 13 (deadline Nov 16)
Filings
Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.
ROUTINE8-KCalidi Biotherapeutics, Inc.CLDWWLIVE ROUTINE8-KCalidi Biotherapeutics, Inc.CLDWWLIVE ROUTINE424B5Calidi Biotherapeutics, Inc.CLDWWLIVE ROUTINE4Calidi Biotherapeutics, Inc.CLDWWLIVE 8 insider filings
James A Schoeneck, insider filing for CLDWW
Show all 8
- 4Insider filing for CLDWW
- 4Insider filing for CLDWW
- 4Insider filing for CLDWW
- 4Insider filing for CLDWW
- 4Insider filing for CLDWW
- 4Insider filing for CLDWW
- 4Insider filing for CLDWW
- 4Insider filing for CLDWW
James A Schoeneck, reporting
ROUTINESCHEDULE 13G/ACalidi Biotherapeutics, Inc.CLDWWLIVE Ownership stake disclosure by ARMISTICE CAPITAL, LLC (amended)
ARMISTICE CAPITAL, LLC, filed by
NOTABLE10-QCalidi Biotherapeutics, Inc.CLDWWLIVE ROUTINE8-KCalidi Biotherapeutics, Inc.CLDWWLIVE ROUTINE8-KCalidi Biotherapeutics, Inc.CLDWWLIVE ROUTINE8-KCalidi Biotherapeutics, Inc.CLDWWLIVE ROUTINE3Calidi Biotherapeutics, Inc.CLDWWLIVE Sanders Corazon (Corsee) D., new insider at CLDWW
Corazon (Corsee) D. Sanders, reporting
ROUTINE8-KCalidi Biotherapeutics, Inc.CLDWWLIVE ROUTINE8-KCalidi Biotherapeutics, Inc.CLDWWLIVE ROUTINEDEFA14ACalidi Biotherapeutics, Inc.CLDWWLIVE ROUTINE8-KCalidi Biotherapeutics, Inc.CLDWWLIVE ROUTINESCHEDULE 13GCalidi Biotherapeutics, Inc.CLDWWLIVE Ownership stake disclosure by ARMISTICE CAPITAL, LLC
ARMISTICE CAPITAL, LLC, filed by
NOTABLE10-QCalidi Biotherapeutics, Inc.CLDWWLIVE ROUTINE8-KCalidi Biotherapeutics, Inc.CLDWWLIVE ROUTINE8-KCalidi Biotherapeutics, Inc.CLDWWLIVE ROUTINEDEFA14ACalidi Biotherapeutics, Inc.CLDWWLIVE ROUTINEDEF 14ACalidi Biotherapeutics, Inc.CLDWWLIVE ROUTINEPRE 14ACalidi Biotherapeutics, Inc.CLDWWLIVE ROUTINE8-KCalidi Biotherapeutics, Inc.CLDWWLIVE NOTABLESCHEDULE 13DCalidi Biotherapeutics, Inc.CLDWWLIVE Ownership stake disclosure by Ognian Anguelov Gavrilov
Ognian Anguelov Gavrilov, filed by
NOTABLE10-KCalidi Biotherapeutics, Inc.CLDWWLIVE ROUTINE8-KCalidi Biotherapeutics, Inc.CLDWWLIVE ROUTINE8-KCalidi Biotherapeutics, Inc.CLDWWLIVE NOTABLESCHEDULE 13DCalidi Biotherapeutics, Inc.CLDWWLIVE Ownership stake disclosure by Ognian Anguelov Gavrilov
Ognian Anguelov Gavrilov, filed by
ROUTINES-3MEFCalidi Biotherapeutics, Inc.CLDWWLIVE ROUTINESCHEDULE 13G/ACalidi Biotherapeutics, Inc.CLDWWLIVE Ownership stake disclosure by Lincoln Alternative Strategies LLC (amended)
Lincoln Alternative Strategies LLC, filed by
ROUTINESCHEDULE 13GCalidi Biotherapeutics, Inc.CLDWWLIVE Ownership stake disclosure by Ognian Anguelov Gavrilov
Ognian Anguelov Gavrilov, filed by
ROUTINE4Calidi Biotherapeutics, Inc.CLDWWLIVE Allan Camaisa, insider filing for CLDWW
Allan Camaisa, reporting
NOTABLE10-QCalidi Biotherapeutics, Inc.CLDWWLIVE MAJOR8-KCalidi Biotherapeutics, Inc.CLDWWLIVE Calidi Biotherapeutics, Inc. (CLDWW) filed an 8-K to report the resignation of its Chief Executive Officer, effective immediately. This unexpected leadership change could create uncertainty and disrupt the company's ongoing clinical trials and commercialization efforts for its…
ROUTINE8-KCalidi Biotherapeutics, Inc.CLDWWLIVE ROUTINE8-KCalidi Biotherapeutics, Inc.CLDWWLIVE